T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
2151
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $465K | ﹤0.01% |
15,893
+1,018
| +7% | +$32.4K |
|
2152
Franklin Covey
FC
$227M
| $463K | ﹤0.01% |
9,897
+121
| +1% | +$5.9K |
|
2153
Kaiser Aluminum
KALU
$2.99B
| $462K | ﹤0.01% |
6,088
-308
| -5% | -$24.7K |
|
2154
Clearfield
CLFD
$390M
| $461K | ﹤0.01% |
4,897
+2,426
| +98% | +$256K |
|
2155
StoneCo
STNE
$2.49B
| $461K | ﹤0.01% |
48,855
+3,700
| +8% | +$38.8K |
|
2156
SunCoke Energy
SXC
$788M
| $461K | ﹤0.01% |
53,409
+1,697
| +3% | +$13.1K |
|
|
GES
2157
DELISTED
Guess Inc
GES
| $460K | ﹤0.01% |
22,212
+115
| +0.5% | +$2.12K |
|
2158
Utz Brands
UTZ
$1.25B
| $460K | ﹤0.01% |
29,004
-4,080
| -12% | -$67.6K |
|
|
MCHB
2159
Mechanics Bancorp
MCHB
$3.79B
| $459K | ﹤0.01% |
16,644
+6,748
| +68% | +$185K |
|
|
AGEN
2160
Agenus
AGEN
$315M
| $458K | ﹤0.01% |
9,726
+377
| +4% | +$19.2K |
|
2161
Cerus
CERS
$572M
| $457K | ﹤0.01% |
125,094
-66,061
| -35% | -$249K |
|
|
ARR
2162
Armour Residential REIT
ARR
$2.37B
| $455K | ﹤0.01% |
16,164
+1,031
| +7% | +$28.1K |
|
|
SNBR
2163
DELISTED
Sleep Number
SNBR
| $455K | ﹤0.01% |
17,504
+1,919
| +12% | +$58.3K |
|
|
TRTX
2164
TPG RE Finance Trust
TRTX
$616M
| $455K | ﹤0.01% |
67,014
+23,254
| +53% | +$171K |
|
2165
NIO
NIO
$11.3B
| $454K | ﹤0.01% |
46,600
| – | – |
|
2166
Dyne Therapeutics
DYN
$4.85B
| $453K | ﹤0.01% |
39,078
+370
| +1% | +$4.28K |
|
|
ETWO
2167
DELISTED
E2open Parent Holdings
ETWO
| $453K | ﹤0.01% |
77,118
+11,438
| +17% | +$65.5K |
|
2168
LivePerson
LPSN
$35.9M
| $453K | ﹤0.01% |
2,978
-1,173
| -28% | -$188K |
|
2169
Virgin Galactic
SPCE
$475M
| $451K | ﹤0.01% |
6,484
-12,445
| -66% | -$1.16M |
|
2170
Cass Information Systems
CASS
$750M
| $449K | ﹤0.01% |
9,805
+913
| +10% | +$38.2K |
|
|
TWOU
2171
DELISTED
2U Inc
TWOU
| $449K | ﹤0.01% |
2,385
+368
| +18% | +$73K |
|
2172
Coeur Mining
CDE
$19B
| $448K | ﹤0.01% |
133,322
+4,642
| +4% | +$16.5K |
|
2173
Opko Health
OPK
$1.04B
| $447K | ﹤0.01% |
357,797
+85,739
| +32% | +$135K |
|
2174
Talos Energy
TALO
$2.58B
| $446K | ﹤0.01% |
23,612
+943
| +4% | +$18.9K |
|
2175
Coursera
COUR
$1.53B
| $445K | ﹤0.01% |
37,605
+1,801
| +5% | +$22.7K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.